These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 8227286)
1. Long-term use of IgA-depleted intravenous immunoglobulin in immunodeficient subjects with anti-IgA antibodies. Cunningham-Rundles C; Zhou Z; Mankarious S; Courter S J Clin Immunol; 1993 Jul; 13(4):272-8. PubMed ID: 8227286 [TBL] [Abstract][Full Text] [Related]
2. Adverse reactions of prophylactic intravenous immunoglobulin infusions in Iranian patients with primary immunodeficiency. Aghamohammadi A; Farhoudi A; Nikzad M; Moin M; Pourpak Z; Rezaei N; Gharagozlou M; Movahedi M; Atarod L; Afshar AA; Bazargan N; Hosseinpoor AR Ann Allergy Asthma Immunol; 2004 Jan; 92(1):60-4. PubMed ID: 14756466 [TBL] [Abstract][Full Text] [Related]
3. Use of an IgA-depleted intravenous immunoglobulin in a patient with an anti-IgA antibody. Cunningham-Rundles C; Wong S; Björkander J; Hanson LA Clin Immunol Immunopathol; 1986 Feb; 38(2):141-9. PubMed ID: 3079685 [TBL] [Abstract][Full Text] [Related]
4. IgG anti-IgA subclasses in common variable immunodeficiency and association with severe adverse reactions to intravenous immunoglobulin therapy. de Albuquerque Campos R; Sato MN; da Silva Duarte AJ J Clin Immunol; 2000 Jan; 20(1):77-82. PubMed ID: 10798611 [TBL] [Abstract][Full Text] [Related]
5. Immune tolerance induction in patients with IgA anaphylactoid reactions following long-term intravenous IgG treatment. Ahrens N; Höflich C; Bombard S; Lochs H; Kiesewetter H; Salama A Clin Exp Immunol; 2008 Mar; 151(3):455-8. PubMed ID: 18234056 [TBL] [Abstract][Full Text] [Related]
6. Effect of intravenous immunoglobulins on in vitro immunoglobulin formation in patients with antibody immunodeficiency. Krátká Z; Bártová J; Krystůfková O; Benetková K; Mrklas L; Fucíková T APMIS; 2002 Mar; 110(3):205-13. PubMed ID: 12076273 [TBL] [Abstract][Full Text] [Related]
7. Anti-IgA antibodies in common variable immunodeficiency (CVID): diagnostic workup and therapeutic strategy. Horn J; Thon V; Bartonkova D; Salzer U; Warnatz K; Schlesier M; Peter HH; Grimbacher B Clin Immunol; 2007 Feb; 122(2):156-62. PubMed ID: 17137841 [TBL] [Abstract][Full Text] [Related]
8. [Successful gamma globulin therapy in a patient with anti-IgA antibodies]. Litzman J; Broz P; Král V; Lokaj J Vnitr Lek; 1997 Feb; 43(2):102-4. PubMed ID: 9245064 [TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up of anti-IgA antibodies in healthy IgA-deficient adults. Koskinen S; Tölö H; Hirvonen M; Koistinen J J Clin Immunol; 1995 Jul; 15(4):194-8. PubMed ID: 7593466 [TBL] [Abstract][Full Text] [Related]
10. Substitution therapy in immunodeficient patients with anti-IgA antibodies or severe adverse reactions to previous immunoglobulin therapy. Eijkhout HW; van den Broek PJ; van der Meer JW Neth J Med; 2003 Jun; 61(6):213-7. PubMed ID: 12948165 [TBL] [Abstract][Full Text] [Related]
11. Immunoglobulin prophylaxis in patients with antibody deficiency syndromes and anti-IgA antibodies. Björkander J; Hammarström L; Smith CI; Buckley RH; Cunningham-Rundles C; Hanson LA J Clin Immunol; 1987 Jan; 7(1):8-15. PubMed ID: 3494039 [TBL] [Abstract][Full Text] [Related]
12. Induction of unresponsiveness against IgA in IgA-deficient patients on subcutaneous immunoglobulin infusion therapy. Sundin U; Nava S; Hammarström L Clin Exp Immunol; 1998 May; 112(2):341-6. PubMed ID: 9649200 [TBL] [Abstract][Full Text] [Related]
13. The role of anti-IgA antibodies in causing adverse reactions to gamma globulin infusion in immunodeficient patients: a comprehensive review of the literature. Rachid R; Bonilla FA J Allergy Clin Immunol; 2012 Mar; 129(3):628-34. PubMed ID: 21835445 [TBL] [Abstract][Full Text] [Related]
14. Anti-IgA antibody associated reactions to intravenous gammaglobulin in a patient who tolerated intramuscular gammaglobulin. Frankel SJ; Polmar SH; Grumet FC; Wedner HJ Ann Allergy; 1986 May; 56(5):436-9. PubMed ID: 2422990 [TBL] [Abstract][Full Text] [Related]
15. Anaphylaxis to IVIG. Williams SJ; Gupta S Arch Immunol Ther Exp (Warsz); 2017 Feb; 65(1):11-19. PubMed ID: 27412077 [TBL] [Abstract][Full Text] [Related]
16. A Severe Anaphylactic Reaction Associated with IgM-Class Anti-Human IgG Antibodies in a Hyper-IgM Syndrome Type 2 Patient. Tsujita Y; Imai K; Honma K; Kamae C; Horiuchi T; Nonoyama S J Clin Immunol; 2018 Jan; 38(1):144-148. PubMed ID: 29255996 [TBL] [Abstract][Full Text] [Related]
17. Immunologic defects in patients with chronic recurrent sinusitis: diagnosis and management. Sethi DS; Winkelstein JA; Lederman H; Loury MC Otolaryngol Head Neck Surg; 1995 Feb; 112(2):242-7. PubMed ID: 7838546 [TBL] [Abstract][Full Text] [Related]